{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:10:42Z","timestamp":1794510642936,"version":"4.9.1"},"reference-count":55,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer's disease (AD) is a growing neurodegenerative disorder causing cognitive decline, memory loss, and functional impairment. Lecanemab has shown safety and efficacy in clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This review aims to understand the clinical evidence of lecanemab's effectiveness and safety in managing early AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search was conducted using the Scopus database and ClinicalTrials.gov. Studies from 2014 to 2024 on lecanemab's safety, efficacy, and clinical outcomes for AD were included. Data extraction involved two independent reviewers, with synthesis using qualitative methodology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Findings from 13 studies and 13 ongoing clinical trials were reported, showing that lecanemab substantially reduces amyloid plaque load in the brains of AD patients. The therapeutic regimens vary across reported studies and trials, ranging from 2.5 mg\/kg biweekly, 5 mg\/kg monthly, 5 mg\/kg biweekly, 10 mg\/kg monthly, and 10 mg\/kg intravenously biweekly. The Clarity AD phase 3 trial, the AHEAD study, and the DIAN-TU-001 trials have reported positive study outcomes with robust efficacy and safety outcomes with minimal side effects. Completed and ongoing trials report on the onset of amyloid-related imaging abnormalities (ARIA) and the continuation of care status following the onset of ARIA in these patients. The common infusion-related reactions were observed in 26.4% of the lecanemab group compared to 7% in the placebo group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The management of AD has evolved over the years with the introduction of novel therapeutic agents like lecanemab. While its safety profile is generally favorable, careful monitoring is essential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13872877251331640","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T10:49:41Z","timestamp":1744714181000},"page":"714-728","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":13,"title":["Exploring the efficacy and safety of lecanemab in the management of early Alzheimer\u2019s disease: A systematic review of clinical evidence"],"prefix":"10.1177","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1613-4452","authenticated-orcid":false,"given":"Rehab Emad","family":"Ashmawy","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Helwan University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3809-4271","authenticated-orcid":false,"given":"Olalekan John","family":"Okesanya","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Science, Neuropsychiatric Hospital, Abeokuta, Nigeria"},{"name":"Faculty of Medicine, Department of Public Health and Maritime Transport, University of Thessaly, Volos, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9367-2612","authenticated-orcid":false,"given":"Bonaventure Michael","family":"Ukoaka","sequence":"additional","affiliation":[{"name":"Community and Clinical Research Division, First On-Call Initiative, Port Harcourt, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1829-4852","authenticated-orcid":false,"given":"Faithful Miebaka","family":"Daniel","sequence":"additional","affiliation":[{"name":"Community and Clinical Research Division, First On-Call Initiative, Port Harcourt, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5634-9708","authenticated-orcid":false,"given":"Sonsochukwu Godfrey","family":"Ezedigwe","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University College Hospital, Ibadan, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6684-6224","authenticated-orcid":false,"given":"Abdulmajeed Opeyemi","family":"Agboola","sequence":"additional","affiliation":[{"name":"Department of Public Health, Al-Hikmah University, Ilorin, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5991-4052","authenticated-orcid":false,"given":"Mohamed Mustaf","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Sciences, SIMAD University, Mogadishu, Somalia"},{"name":"Department of Research and Innovations, eHealth Somalia, Mogadishu, Somalia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3595-8643","authenticated-orcid":false,"given":"Jerico Bautista","family":"Ogaya","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, Institute of Health Sciences and Nursing, Far Eastern University, Manila, Philippines"},{"name":"Center for University Research, University of Makati, Makati City, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6647-5696","authenticated-orcid":false,"given":"Blessing Olawunmi","family":"Amisu","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Services, State Hospital, Ede, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2375-6375","authenticated-orcid":false,"given":"Olaniyi Abideen","family":"Adigun","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Science, Nigerian Defence Academy, Kaduna, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3997-4360","authenticated-orcid":false,"given":"Olanegan Gloria","family":"Oluwakemi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Ilorin, Kwara State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2000-4558","authenticated-orcid":false,"given":"Ayaat Mohamed","family":"Hamza","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Helwan University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7821-500X","authenticated-orcid":false,"given":"Marina Ramzy","family":"Mourid","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1805-0570","authenticated-orcid":false,"given":"MBN","family":"Kouwenhoven","sequence":"additional","affiliation":[{"name":"Department of Physics, Xi\u2019an Jiaotong-Liverpool University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2179-6365","authenticated-orcid":false,"suffix":"III","given":"Don Eliseo","family":"Lucero-Prisno","sequence":"additional","affiliation":[{"name":"Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK"},{"name":"Research and Innovation Office, Southern Leyte State University, Sogod, Philippines"},{"name":"The Office of Research, St. Paul University Iloilo, Iloilo City, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32205-4"},{"key":"e_1_3_4_3_2","article-title":"Current and evolving treatment strategies for the Alzheimer disease continuum","volume":"26","author":"Marasco RA","year":"2020","unstructured":"Marasco RA. Current and evolving treatment strategies for the Alzheimer disease continuum. Am J Manag Care 2020; 26: S167\u2013S176.","journal-title":"Am J Manag Care"},{"key":"e_1_3_4_4_2","article-title":"Alzheimer\u2019s disease drug development in an evolving therapeutic landscape","volume":"10","author":"Weninger S","year":"2024","unstructured":"Weninger S, Irizarry MC, Fleisher AS, et al. Alzheimer\u2019s disease drug development in an evolving therapeutic landscape. Alzheimers Dement (N Y) 2024; 10: e70015.","journal-title":"Alzheimers Dement (N Y)"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-023-00976-6"},{"key":"e_1_3_4_6_2","article-title":"Alzheimer\u2019s drug aducanumab to be discontinued \u2013 Dementia Community","author":"JDCteam","year":"2024","unstructured":"JDCteam. Alzheimer\u2019s drug aducanumab to be discontinued \u2013 Dementia Community. Journal of Dementia Care. https:\/\/journalofdementiacare.co.uk\/aducanumab-to-be-discontinued (2024. accessed 17 March 2025).","journal-title":"Journal of Dementia Care"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.09.001"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00813-8"},{"key":"e_1_3_4_9_2","article-title":"Validation of plasma amyloid-\u03b2 42\/40 for detecting Alzheimer disease amyloid plaques","volume":"98","author":"Li Y","year":"2022","unstructured":"Li Y, Schindler SE, Bollinger JG, et al. Validation of plasma amyloid-\u03b2 42\/40 for detecting Alzheimer disease amyloid plaques. Neurology 2022; 98: e688\u2013e699.","journal-title":"Neurology"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-019-00068-4"},{"key":"e_1_3_4_11_2","first-page":"109","article-title":"Defining disease modifying therapy for Alzheimer\u2019s disease","volume":"4","author":"Cummings J","year":"2017","unstructured":"Cummings J, Fox N. Defining disease modifying therapy for Alzheimer\u2019s disease. J Prev Alzheimers Dis 2017; 4: 109\u2013115.","journal-title":"J Prev Alzheimers Dis"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2023.30"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.870517"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-020-0687-6"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2018.03.009"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000055"},{"key":"e_1_3_4_17_2","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.","journal-title":"BMJ"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00473-w"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00460-1"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-022-00350-y"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-230589"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01124-2"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2023.123"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2024.103949"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.069405"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.94.15_supplement.1330"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-016-0181-2"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-140741"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01129-x"},{"key":"e_1_3_4_31_2","unstructured":"Brain of Woman Who Died on Leqembi Shows Worst-Case Scenario | ALZFORUM. Alzforum https:\/\/www.alzforum.org\/news\/research-news\/brain-woman-who-died-leqembi-shows-worst-case-scenario (2024 accessed 17 March 2025)."},{"key":"e_1_3_4_32_2","unstructured":"Eisai Biogen rocked by 2nd lecanemab death report ahead of Alzheimer\u2019s data reveal | Fierce Biotech. Fierce Biotech https:\/\/www.fiercebiotech.com\/biotech\/eisai-biogen-rocked-second-alzheimers-death-report-ahead-lecanemab-data-reveal (2022 accessed 17 March 2025)."},{"key":"e_1_3_4_33_2","unstructured":"Big Pharma Is Pushing Potentially Deadly Alzheimer\u2019s Drugs. Jacobin https:\/\/jacobin.com\/2025\/02\/alzheimers-drugs-approval-regulations-death (2025 accessed 17 March 2025)."},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.94.15_supplement.133"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1134-4"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1088\/0953-8984\/24\/24\/244102"},{"key":"e_1_3_4_37_2","first-page":"428","article-title":"Lecanemab unveiled: exploring Alzheimer\u2019s treatment advancements, assessing strengths, limitations, and its therapeutic landscape position","volume":"37","author":"Adepoju VA","year":"2024","unstructured":"Adepoju VA, Onyezue OI, Jamil S, et al. Lecanemab unveiled: exploring Alzheimer\u2019s treatment advancements, assessing strengths, limitations, and its therapeutic landscape position. Biomed Environ Sci 2024; 37: 428\u2013431.","journal-title":"Biomed Environ Sci"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100657"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-022-00373-5"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2023.29.9.1078"},{"key":"e_1_3_4_41_2","article-title":"Meaningful benefit and minimal clinically important difference (MCID) in Alzheimer\u2019s disease: open peer commentary","volume":"9","author":"Cummings J.","year":"2023","unstructured":"Cummings J. Meaningful benefit and minimal clinically important difference (MCID) in Alzheimer\u2019s disease: open peer commentary. Alzheimers Dement (N Y) 2023; 9: e12411.","journal-title":"Alzheimers Dement (N Y)"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01441-8"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.100982"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00663-w"},{"key":"e_1_3_4_45_2","unstructured":"Understanding Leqembi\u2019s Side Effects: A Guide for Patients. Penn Medicine https:\/\/pennmemorycenter.org\/wp-content\/uploads\/2024\/06\/Leqembi-Side-Effects-Handout-1.pdf."},{"key":"e_1_3_4_46_2","article-title":"ARIA In patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer\u2019s disease","volume":"9","author":"Honig LS","year":"2023","unstructured":"Honig LS, Barakos J, Dhadda S, et al. ARIA In patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer\u2019s disease. Alzheimers Dement (N Y) 2023; 9: e12377.","journal-title":"Alzheimers Dement (N Y)"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1326784"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1169499"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1177\/09727531231187235"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0377-8"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-023-00404-2"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1177\/03946320231209839"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00492-7"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-019-0609-7"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1186\/s43058-020-00023-7"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12737"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877251331640","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13872877251331640","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877251331640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:10:23Z","timestamp":1777371023000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13872877251331640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1177\/13872877251331640"],"URL":"https:\/\/doi.org\/10.1177\/13872877251331640","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]}}}